West Virginia University Hospitals, INC

West Virginia University Hospitals, INC was paid $124.09M by Medicaid between Jan 2018 and Dec 2024, across 830 billing codes. Its largest line is 99285, emergency room visit (most serious) — 5.6% of everything it billed.

33Billing provider infoWEST VIRGINIA UNIVERSITY HOSPITALS, INC
MORGANTOWN, WV 26506

33aNPI1841271459assigned 11/10/2005

33bProvider typeClinical Medical Laboratory

28Total paid$124.09M

24GClaims2,888,713

24DCodes billed830

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in West Virginia

Rank by total paid#2 of 36

Median peer was paid$61K

This provider vs. median2,031×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	417,980	$36.08M
2019	349,973	$23.31M
2020	587,939	$32.51M
2021	574,311	$14.31M
2022	292,403	$5.27M
2023	376,095	$6.59M
2024incomplete	290,012	$6.02M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.6%	18,764	16,027	$6.93M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.6%	34,392	30,163	$5.74M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.5%	178,054	155,995	$4.34M
J9271	Injection, pembrolizumab, 1 mg	3.4%	791	519	$4.16M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.2%	29,725	27,178	$2.78M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.2%	153,553	112,684	$2.72M
J0585	Injection, onabotulinumtoxina, 1 unit	1.6%	4,367	3,338	$2.04M
80053	Comprehensive metabolic panel	1.6%	70,537	56,593	$1.96M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.5%	8,112	7,283	$1.83M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.4%	94,769	75,815	$1.80M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.4%	25,541	18,857	$1.78M
J7120	Ringers lactate infusion, up to 1000 cc	1.3%	30,281	21,332	$1.62M

818 more codes

80048	Basic metabolic panel (calcium, ionized)	1.3%	67,667	$1.58M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	8,952	$1.53M
J2405	Injection, ondansetron hydrochloride, per 1 mg	1.2%	33,801	$1.51M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.2%	16,328	$1.50M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	1.2%	1,870	$1.49M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.1%	53,867	$1.41M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.1%	12,100	$1.34M
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	27,388	$1.22M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	73,224	$1.20M
G0378	Hospital observation service, per hour	<1%	13,373	$1.08M
84443	Thyroid stimulating hormone (TSH)	<1%	41,086	$1.03M
J2505	Injection, pegfilgrastim, 6 mg	<1%	456	$917K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	17,278	$910K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,370	$902K
41899	Unlisted procedure, dentoalveolar structures	<1%	620	$898K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	9,683	$858K
96375	Therapeutic injection; each additional sequential IV push	<1%	20,734	$833K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	11,631	$782K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,097	$766K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	491	$752K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	11,994	$751K
J0178	Injection, aflibercept, 1 mg	<1%	1,131	$747K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	17,059	$746K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	20,939	$746K
70450	Computed tomography, head or brain; without contrast material	<1%	7,623	$722K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	19,210	$690K
81001		<1%	41,446	$669K
36430		<1%	1,519	$667K
J0690	Injection, cefazolin sodium, 500 mg	<1%	10,902	$636K
86850		<1%	24,329	$619K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	299	$602K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,140	$601K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	8,819	$585K
85610		<1%	29,081	$573K
96361	Intravenous infusion, hydration; each additional hour	<1%	7,656	$566K
71045	Radiologic examination, chest; single view	<1%	18,089	$556K
83735		<1%	38,585	$549K
77386		<1%	1,197	$544K
J0897	Injection, denosumab, 1 mg	<1%	555	$540K
Q3014	Telehealth originating site facility fee	<1%	23,401	$540K
86900		<1%	24,027	$505K
86901		<1%	23,989	$496K
87086	Culture, bacterial; quantitative colony count, urine	<1%	26,213	$492K
67028	Intravitreal injection of a pharmacologic agent	<1%	4,083	$491K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	13,124	$486K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	13,107	$485K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	5,325	$483K
84484		<1%	20,157	$475K
71046	Radiologic examination, chest; 2 views	<1%	13,979	$462K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	14,411	$451K
85027		<1%	28,138	$444K
82248		<1%	31,749	$439K
96417		<1%	2,804	$432K
85730		<1%	15,493	$430K
93325		<1%	4,570	$427K
82565		<1%	21,572	$416K
84460		<1%	22,076	$413K
84450		<1%	22,213	$402K
83036	Hemoglobin; glycosylated (A1C)	<1%	24,693	$393K
96367		<1%	6,013	$388K
64615		<1%	2,736	$387K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	9,926	$387K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	13,220	$377K
95782		<1%	408	$368K
80061	Lipid panel	<1%	19,265	$366K
82803		<1%	10,752	$365K
84702		<1%	13,173	$356K
99213	Doctor's office visit, returning patient (routine)	<1%	14,415	$355K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,098	$354K
92134		<1%	7,907	$354K
95813		<1%	1,360	$353K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,794	$350K
84100		<1%	29,202	$349K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	641	$345K
83605		<1%	11,867	$344K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,025	$328K
64493		<1%	945	$321K
76770		<1%	4,950	$321K
70496		<1%	1,508	$320K
84075		<1%	15,017	$318K
J9299	Injection, nivolumab, 1 mg	<1%	55	$314K
92060		<1%	13,290	$299K
96415		<1%	3,022	$297K
C1769	Guide wire	<1%	3,347	$288K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	5,140	$288K
0099U		<1%	686	$285K
70498		<1%	1,370	$284K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,396	$279K
71250		<1%	3,016	$279K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,155	$277K
96376		<1%	7,877	$274K
86140		<1%	19,160	$274K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,286	$274K
93308		<1%	2,976	$273K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,675	$273K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	5,836	$271K
84520		<1%	14,556	$268K
82247		<1%	14,446	$265K
36415	Collection of venous blood by venipuncture	<1%	57,296	$263K
20610		<1%	2,993	$262K
80051		<1%	10,808	$259K
77334		<1%	976	$255K
87631		<1%	2,014	$253K
82805		<1%	2,265	$250K
96368		<1%	2,315	$243K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	18,861	$242K
83615		<1%	15,658	$239K
84439		<1%	10,590	$237K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,216	$236K
88307		<1%	1,406	$236K
83690		<1%	13,508	$225K
93226		<1%	954	$222K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	597	$221K
84703		<1%	4,605	$216K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	9,843	$207K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,913	$205K
93320		<1%	1,787	$205K
84132		<1%	4,961	$203K
82728		<1%	9,319	$196K
77336		<1%	2,031	$193K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	603	$190K
88185		<1%	1,715	$189K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	716	$189K
88341		<1%	1,586	$188K
83880		<1%	5,935	$184K
76830	Ultrasound, transvaginal	<1%	2,183	$184K
78815	Positron emission tomography (PET) for limited area imaging	<1%	591	$184K
85652		<1%	12,910	$183K
77300		<1%	585	$176K
31575		<1%	1,964	$176K
82330		<1%	4,190	$175K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	3,237	$174K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,732	$173K
93271		<1%	781	$173K
82607		<1%	7,374	$172K
88342		<1%	3,062	$172K
G0379	Direct admission of patient for hospital observation care	<1%	707	$172K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,395	$172K
86003		<1%	2,351	$171K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,107	$167K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	6,941	$167K
J9312	Injection, rituximab, 10 mg	<1%	58	$167K
87077		<1%	8,835	$167K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	6,235	$165K
J0185	Injection, aprepitant, 1 mg	<1%	334	$164K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	776	$162K
82310		<1%	11,044	$162K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	5,554	$161K
87340		<1%	8,277	$160K
84466		<1%	8,059	$158K
88142		<1%	5,359	$157K
87040		<1%	4,163	$155K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	757	$154K
86803		<1%	8,491	$152K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,322	$151K
76942		<1%	1,093	$150K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,236	$147K
76642		<1%	2,147	$143K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,674	$143K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	1,592	$142K
80076		<1%	5,840	$142K
77412		<1%	815	$142K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	3,973	$141K
64494		<1%	834	$141K
94060		<1%	1,990	$141K
92133		<1%	3,825	$140K
88304		<1%	1,920	$140K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,546	$138K
83540		<1%	9,018	$137K
82570		<1%	10,161	$135K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,525	$131K
70491		<1%	422	$130K
95951		<1%	422	$129K
62323		<1%	547	$128K
76825		<1%	620	$127K
73630		<1%	4,617	$127K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,623	$124K
83970		<1%	3,927	$124K
73564		<1%	4,108	$123K
84295		<1%	3,412	$123K
73610		<1%	4,143	$123K
J2785	Injection, regadenoson, 0.1 mg	<1%	652	$120K
87653		<1%	2,488	$117K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	3,296	$117K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	934	$115K
82784		<1%	5,477	$115K
87522	Neg quan hep c or qual rna	<1%	2,099	$115K
J0475	Injection, baclofen, 10 mg	<1%	172	$112K
81002		<1%	11,345	$111K
73110		<1%	2,957	$111K
84156		<1%	5,919	$110K
82947		<1%	2,577	$109K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	220	$109K
82746		<1%	4,604	$108K
70486		<1%	700	$107K
17110		<1%	628	$107K
76536		<1%	1,349	$107K
95811		<1%	172	$106K
82977		<1%	3,737	$105K
92250		<1%	6,137	$105K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	540	$105K
72110		<1%	2,598	$104K
73130		<1%	2,792	$104K
82550		<1%	5,258	$104K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	2,224	$103K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,876	$102K
99203	Doctor's office visit, new patient (routine)	<1%	3,541	$102K
87070		<1%	5,045	$102K
72082		<1%	2,624	$102K
87481		<1%	1,812	$101K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,129	$99K
86592		<1%	4,796	$98K
92082		<1%	4,357	$97K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	4,386	$96K
73030		<1%	3,972	$95K
90472	Immunization administration, each additional vaccine (list separately)	<1%	6,355	$95K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	6,657	$95K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	7,381	$93K
93321		<1%	697	$92K
72170		<1%	2,183	$92K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	766	$92K
82378		<1%	2,550	$91K
82435		<1%	817	$91K
76827		<1%	619	$90K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,678	$89K
87186		<1%	6,529	$89K
87210		<1%	4,532	$87K
97161		<1%	1,479	$87K
93971		<1%	1,577	$87K
73590		<1%	2,855	$86K
83516		<1%	3,840	$86K
82040		<1%	8,475	$86K
90715		<1%	3,265	$84K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	194	$84K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	311	$84K
86762		<1%	4,233	$83K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	108	$83K
93017		<1%	1,136	$83K
87205		<1%	4,822	$82K
93225		<1%	959	$82K
80050	General health panel	<1%	2,120	$81K
77002		<1%	282	$80K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,508	$79K
94729		<1%	1,985	$79K
74018		<1%	2,414	$78K
97162		<1%	1,924	$78K
88313		<1%	827	$78K
74178		<1%	360	$78K
29075		<1%	449	$77K
20553		<1%	510	$76K
88184		<1%	1,787	$75K
93970		<1%	771	$75K
93304		<1%	250	$75K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,095	$74K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	746	$72K
95886		<1%	1,076	$71K
93270		<1%	781	$70K
73552		<1%	2,632	$69K
76801		<1%	911	$69K
73090		<1%	1,818	$69K
86923		<1%	1,189	$69K
81025		<1%	2,310	$67K
94726		<1%	1,643	$67K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,811	$66K
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	<1%	406	$65K
87081		<1%	4,589	$65K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	828	$65K
86706		<1%	3,305	$65K
73080		<1%	1,933	$64K
86480		<1%	1,222	$62K
90686		<1%	4,618	$62K
80069		<1%	3,046	$62K
77066	Tomosynthesis, mammo	<1%	560	$61K
77065	Tomosynthesis, mammo	<1%	1,018	$60K
85379		<1%	2,034	$58K
96377		<1%	624	$57K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,206	$57K
97166		<1%	1,508	$56K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,357	$56K
86704		<1%	2,374	$56K
95715		<1%	155	$55K
64635		<1%	146	$55K
86038		<1%	2,182	$55K
82105		<1%	1,732	$54K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	522	$54K
73522		<1%	1,629	$53K
C1760	Closure device, vascular (implantable/insertable)	<1%	206	$53K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,512	$52K
97165		<1%	869	$52K
92567		<1%	3,690	$52K
72040		<1%	1,849	$51K
74019		<1%	1,983	$51K
59025	Fetal non-stress test	<1%	1,379	$51K
90732		<1%	759	$51K
90670		<1%	2,200	$50K
73562		<1%	1,423	$50K
86255		<1%	1,453	$50K
73560		<1%	2,103	$50K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	874	$49K
94010		<1%	2,068	$49K
84481		<1%	1,305	$49K
84550		<1%	3,254	$48K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	906	$48K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	2,202	$48K
72050		<1%	993	$47K
87536		<1%	563	$47K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	743	$47K
11102		<1%	364	$47K
92557		<1%	1,510	$46K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,704	$46K
J3471	Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)	<1%	210	$46K
90658		<1%	2,542	$45K
82140		<1%	1,789	$45K
81513		<1%	936	$45K
82785		<1%	1,863	$45K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	986	$45K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	1,159	$44K
73502		<1%	1,868	$44K
85018		<1%	3,249	$43K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	3,108	$43K
93296		<1%	4,424	$42K
86235		<1%	737	$42K
96411		<1%	595	$41K
96401		<1%	205	$40K
11100		<1%	323	$40K
88112		<1%	895	$39K
93880		<1%	613	$39K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,256	$39K
70250		<1%	257	$39K
95911		<1%	274	$39K
J9045	Injection, carboplatin, 50 mg	<1%	523	$39K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,477	$39K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	550	$39K
96402		<1%	408	$38K
84146		<1%	1,189	$38K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,451	$38K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,864	$38K
90651		<1%	644	$38K
82657		<1%	375	$38K
0064U		<1%	1,073	$37K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	606	$37K
95700		<1%	316	$37K
82043		<1%	3,827	$37K
77295		<1%	127	$37K
72100		<1%	1,467	$36K
75574		<1%	217	$36K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	841	$36K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	31	$36K
73140		<1%	718	$35K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,489	$35K
87486		<1%	371	$35K
87581		<1%	370	$35K
90750		<1%	352	$35K
74174		<1%	335	$34K
83520		<1%	988	$34K
80055		<1%	870	$33K
83001		<1%	978	$32K
89051		<1%	916	$32K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	782	$31K
J3490	Unclassified drugs	<1%	11,335	$31K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	777	$31K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	365	$31K
93923		<1%	824	$31K
94664		<1%	569	$30K
95885		<1%	469	$30K
31231		<1%	294	$30K
86300		<1%	1,501	$30K
88173		<1%	247	$30K
73060		<1%	1,144	$30K
51798		<1%	1,810	$29K
82533		<1%	660	$29K
J1453	Injection, fosaprepitant, 1 mg	<1%	922	$29K
86790		<1%	1,456	$29K
J8501	Aprepitant, oral, 5 mg	<1%	476	$28K
74230		<1%	291	$28K
88360		<1%	184	$28K
92611		<1%	214	$28K
77080		<1%	503	$28K
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	121	$28K
86618		<1%	1,347	$28K
36592		<1%	727	$27K
87902		<1%	146	$27K
86160		<1%	734	$27K
C1874	Stent, coated/covered, with delivery system	<1%	12	$27K
82950		<1%	2,908	$27K
76882		<1%	646	$27K
95806		<1%	448	$26K
95874		<1%	337	$26K
36561		<1%	32	$25K
V2632	Posterior chamber intraocular lens	<1%	539	$25K
80197		<1%	2,451	$25K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	516	$24K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	184	$24K
95910		<1%	294	$24K
86780		<1%	2,744	$24K
85046		<1%	1,808	$24K
82670		<1%	587	$24K
83883		<1%	674	$23K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	338	$23K
84403		<1%	872	$23K
72072		<1%	642	$23K
87147		<1%	826	$22K
J2060	Injection, lorazepam, 2 mg	<1%	1,273	$22K
84165		<1%	1,225	$22K
87015		<1%	756	$22K
99201		<1%	1,499	$22K
76813		<1%	357	$22K
J2704	Injection, propofol, 10 mg	<1%	13,599	$22K
86334		<1%	545	$22K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	635	$21K
52000		<1%	115	$21K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,035	$21K
62369		<1%	200	$21K
86376		<1%	775	$21K
80164		<1%	1,279	$20K
99495		<1%	478	$20K
86431		<1%	1,090	$20K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	64	$20K
96112		<1%	238	$20K
93925		<1%	316	$20K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	367	$20K
11104		<1%	136	$20K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	500	$20K
72131		<1%	143	$20K
90671		<1%	381	$20K
74022		<1%	368	$19K
95819		<1%	87	$19K
36591		<1%	1,977	$19K
77387		<1%	95	$19K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	295	$19K
76937		<1%	449	$19K
29425		<1%	137	$19K
92587		<1%	726	$18K
0065U		<1%	2,381	$18K
Q9960	High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml	<1%	214	$18K
77001		<1%	224	$18K
58300		<1%	136	$18K
10060		<1%	182	$18K
86200		<1%	791	$17K
83655		<1%	1,237	$17K
87075		<1%	439	$17K
88312		<1%	209	$17K
73501		<1%	671	$17K
87799		<1%	472	$17K
87102		<1%	620	$17K
84153		<1%	1,011	$17K
64642		<1%	103	$17K
88275		<1%	36	$16K
64483		<1%	62	$16K
51600		<1%	63	$16K
84155		<1%	1,775	$16K
64490		<1%	32	$16K
92579		<1%	536	$16K
64491		<1%	32	$16K
94762		<1%	161	$16K
J9070	Cyclophosphamide, 100 mg	<1%	37	$15K
86147		<1%	233	$15K
95115		<1%	1,829	$15K
73100		<1%	316	$15K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	772	$15K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	285	$15K
73700		<1%	147	$15K
20611		<1%	148	$15K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	550	$15K
92504		<1%	804	$14K
87184		<1%	846	$14K
84425		<1%	703	$14K
86317		<1%	953	$14K
86304		<1%	571	$14K
87324		<1%	536	$14K
96132		<1%	457	$14K
86870		<1%	430	$14K
78999		<1%	130	$14K
71271		<1%	337	$14K
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	86	$13K
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	87	$13K
81514		<1%	175	$13K
J3300	Injection, triamcinolone acetonide, preservative free, 1 mg	<1%	18	$13K
G0008	Administration of influenza virus vaccine	<1%	639	$13K
88311		<1%	418	$13K
77280		<1%	36	$13K
83002		<1%	400	$13K
84145		<1%	807	$13K
90791	Psychiatric diagnostic evaluation	<1%	372	$13K
64636		<1%	79	$13K
82150		<1%	491	$13K
Q4038	Cast supplies, short leg cast, adult (11 years +), fiberglass	<1%	172	$12K
85049		<1%	678	$12K
88271		<1%	36	$12K
J2997	Injection, alteplase recombinant, 1 mg	<1%	92	$11K
81015		<1%	352	$11K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	186	$11K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	456	$11K
J3480	Injection, potassium chloride, per 2 meq	<1%	784	$11K
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	62	$11K
77072		<1%	364	$11K
87181		<1%	394	$11K
81003		<1%	419	$11K
86146		<1%	126	$11K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	96	$11K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	12	$10K
C1729	Catheter, drainage	<1%	254	$10K
J1940	Injection, furosemide, up to 20 mg	<1%	679	$10K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	180	$10K
87497		<1%	338	$10K
84590		<1%	749	$10K
82172		<1%	215	$10K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	135	$10K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	1,270	$10K
77470		<1%	31	$10K
83010		<1%	229	$10K
82374		<1%	14	$10K
86709		<1%	554	$10K
82390		<1%	309	$10K
74220		<1%	113	$9K
95117		<1%	646	$9K
74455		<1%	45	$9K
86920		<1%	266	$9K
92136		<1%	580	$9K
83721		<1%	555	$9K
69210		<1%	55	$8K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	28	$8K
12001		<1%	87	$8K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	67	$8K
82103		<1%	373	$8K
85613		<1%	123	$8K
72190		<1%	188	$8K
64405		<1%	32	$8K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	300	$8K
78264		<1%	39	$8K
86665		<1%	341	$7K
84402		<1%	399	$7K
99204	Doctor's office visit, new patient (more involved)	<1%	368	$7K
83525		<1%	325	$7K
93298		<1%	535	$7K
82010		<1%	487	$7K
86301		<1%	224	$7K
77073		<1%	211	$7K
87209		<1%	160	$7K
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	260	$7K
86833		<1%	31	$7K
80175		<1%	275	$7K
94618		<1%	33	$7K
76870		<1%	80	$6K
86832		<1%	30	$6K
29125		<1%	41	$6K
86364		<1%	613	$6K
76820		<1%	346	$6K
87177		<1%	160	$6K
82542		<1%	169	$6K
73070		<1%	172	$6K
78832		<1%	20	$6K
17000		<1%	52	$6K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	89	$6K
84446		<1%	175	$6K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	1,433	$6K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	186	$6K
87045		<1%	136	$6K
88237		<1%	17	$6K
92020		<1%	396	$6K
80177		<1%	500	$6K
76775		<1%	104	$6K
88264		<1%	16	$6K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	428	$6K
90474		<1%	723	$6K
82232		<1%	303	$6K
81508		<1%	88	$6K
70480		<1%	43	$6K
87046		<1%	136	$5K
80143		<1%	473	$5K
J1815	Injection, insulin, per 5 units	<1%	1,306	$5K
J1630	Injection, haloperidol, up to 5 mg	<1%	242	$5K
74221		<1%	19	$5K
77370		<1%	15	$5K
84157		<1%	193	$5K
90832	Psychotherapy session, about 30 minutes	<1%	113	$5K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	252	$5K
93799		<1%	1,004	$5K
90636		<1%	67	$5K
99215	Doctor's office visit, returning patient (complex)	<1%	228	$5K
92285		<1%	106	$5K
74183		<1%	66	$4K
86696		<1%	250	$4K
93288		<1%	306	$4K
80179		<1%	390	$4K
51728		<1%	47	$4K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	146	$4K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	146	$4K
83930		<1%	83	$4K
84300		<1%	213	$4K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	94	$4K
77061		<1%	335	$4K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	91	$4K
90648		<1%	2,202	$4K
90723		<1%	1,587	$4K
86308		<1%	77	$4K
87529		<1%	82	$4K
93458		<1%	26	$4K
95971		<1%	83	$4K
0097U		<1%	72	$4K
90734		<1%	431	$4K
83521		<1%	245	$3K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	42	$3K
J9267	Injection, paclitaxel, 1 mg	<1%	83	$3K
91320		<1%	133	$3K
86664		<1%	211	$3K
99490	Ccm add 20min	<1%	659	$3K
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,281	$3K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	164	$3K
83835		<1%	28	$3K
86800		<1%	101	$3K
87427		<1%	129	$3K
86695		<1%	250	$3K
82787		<1%	209	$3K
90680		<1%	1,110	$3K
87329		<1%	25	$3K
87328		<1%	25	$3K
Q4010	Cast supplies, short arm cast, adult (11 years +), fiberglass	<1%	27	$3K
12011		<1%	40	$3K
J9370	Vincristine sulfate, 1 mg	<1%	239	$3K
0001A		<1%	129	$3K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	92	$3K
96156		<1%	64	$3K
83519		<1%	32	$3K
82139		<1%	95	$3K
J7609	Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg	<1%	26	$3K
73523		<1%	46	$3K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	107	$3K
83921		<1%	121	$3K
86617		<1%	140	$3K
90633		<1%	917	$3K
73000		<1%	113	$3K
84305		<1%	86	$3K
83935		<1%	63	$2K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	101	$2K
87116		<1%	75	$2K
77290		<1%	15	$2K
0124A		<1%	207	$2K
0002A		<1%	100	$2K
80074		<1%	49	$2K
78830		<1%	28	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,843	$2K
82525		<1%	121	$2K
88720		<1%	244	$2K
96133		<1%	161	$2K
49083		<1%	24	$2K
76981		<1%	30	$2K
99205	Prolong outpt/office vis	<1%	96	$2K
93289		<1%	97	$2K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	14	$2K
93922		<1%	37	$2K
78306		<1%	22	$2K
92015	Determination of refractive state	<1%	903	$2K
11730		<1%	13	$2K
29065		<1%	17	$2K
84445		<1%	28	$2K
93242		<1%	363	$2K
82340		<1%	52	$2K
90707		<1%	288	$2K
72141		<1%	43	$2K
86141		<1%	114	$2K
A6204	Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	<1%	48	$2K
86644		<1%	77	$2K
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	58	$2K
82164		<1%	86	$2K
86774		<1%	158	$2K
88300		<1%	113	$2K
90716		<1%	244	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	9,030	$2K
73120		<1%	40	$2K
86787		<1%	107	$2K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	276	$2K
95909		<1%	40	$2K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,160	$1K
70030		<1%	48	$1K
84134		<1%	136	$1K
97535	Self-care/home management training, each 15 minutes	<1%	439	$1K
81596		<1%	17	$1K
83021		<1%	13	$1K
85384		<1%	42	$1K
77003		<1%	16	$1K
58301		<1%	14	$1K
12002		<1%	12	$1K
87206		<1%	72	$1K
99173		<1%	175	$1K
80178		<1%	153	$1K
93299		<1%	70	$1K
0004A		<1%	123	$1K
86645		<1%	82	$1K
88230		<1%	15	$1K
95970		<1%	14	$1K
92551		<1%	127	$1K
99406		<1%	69	$1K
90480		<1%	192	$1K
90656		<1%	370	$1K
84166		<1%	13	$1K
64643		<1%	16	$1K
90700		<1%	290	$994.38
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	698	$986.22
80081		<1%	15	$943.18
99443		<1%	44	$938.60
99487	Ccm add 20min	<1%	168	$926.53
0054A		<1%	70	$923.19
84630		<1%	100	$903.72
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	244	$889.26
88302		<1%	45	$867.29
99496		<1%	13	$859.16
84207		<1%	41	$855.10
83993		<1%	57	$844.26
82945		<1%	115	$839.46
43235		<1%	12	$837.00
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	132	$836.25
83986		<1%	14	$834.18
72156		<1%	26	$826.92
90657		<1%	152	$822.66
96127		<1%	322	$821.24
90694		<1%	228	$811.57
86769		<1%	15	$802.35
82962		<1%	642	$784.64
92555		<1%	40	$774.03
76885		<1%	18	$751.33
51705		<1%	12	$749.63
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	31	$747.26
11721		<1%	12	$742.84
82017		<1%	13	$713.59
72128		<1%	13	$637.42
93312		<1%	13	$631.06
89230		<1%	13	$564.92
99441		<1%	57	$546.84
10005		<1%	17	$533.06
90662		<1%	27	$530.65
86812		<1%	26	$494.48
99442		<1%	46	$490.00
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	<1%	93	$489.87
86922		<1%	18	$464.15
86705		<1%	45	$448.17
90746		<1%	12	$443.33
93246		<1%	80	$437.26
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	142	$412.94
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	3,066	$383.96
92610		<1%	13	$382.78
82627		<1%	19	$372.35
83090		<1%	13	$347.90
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	863	$344.40
90834	Psychotherapy session, about 45 minutes	<1%	12	$325.60
97803		<1%	12	$323.48
80306		<1%	30	$307.43
86039		<1%	30	$303.51
83498		<1%	12	$302.42
80202		<1%	24	$293.92
36416		<1%	63	$293.67
76604		<1%	13	$278.44
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	257	$270.20
99024		<1%	41	$268.09
82085		<1%	29	$258.99
84270		<1%	16	$257.13
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	1,087	$252.06
76512		<1%	27	$243.80
87338		<1%	18	$232.36
A9561	Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	<1%	21	$232.10
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	168	$231.57
74420		<1%	12	$229.83
92025		<1%	30	$228.79
72081		<1%	14	$222.58
90710		<1%	73	$201.79
86316		<1%	12	$200.09
96416		<1%	21	$192.65
99177		<1%	75	$182.55
90696		<1%	53	$181.94
93243		<1%	20	$164.66
90655		<1%	51	$164.08
90653		<1%	45	$151.63
C1726	Catheter, balloon dilatation, non-vascular	<1%	181	$151.40
80047		<1%	17	$148.32
97804		<1%	54	$140.79
83020		<1%	13	$133.88
85306		<1%	14	$130.77
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	91	$125.73
0134A		<1%	16	$123.68
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	25	$120.61
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,195	$114.70
A4648	Tissue marker, implantable, any type, each	<1%	66	$113.98
96040		<1%	16	$99.81
87088		<1%	14	$98.92
86849		<1%	12	$98.72
80156		<1%	14	$95.94
82365		<1%	16	$95.76
83695		<1%	12	$81.06
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	1,995	$73.87
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	294	$67.33
84436		<1%	16	$55.62
J9190	Injection, fluorouracil, 500 mg	<1%	18	$50.47
99152		<1%	116	$43.19
85347		<1%	12	$41.25
94760		<1%	41	$40.30
96139		<1%	67	$35.46
96138		<1%	69	$34.69
A9573	Injection, gadopiclenol, 1 ml	<1%	386	$30.54
99153	Mod sedat endo service >5yrs	<1%	75	$24.59
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	26	$20.65
91312		<1%	31	$19.24
C1889	Implantable/insertable device, not otherwise classified	<1%	58	$15.47
V2788	Presbyopia correcting function of intraocular lens	<1%	16	$7.76
93356		<1%	123	$6.50
J1171	Injection, hydromorphone, 0.1 mg	<1%	77	$4.50
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	16	$4.08
91300		0%	127	$0.00
80360		0%	13	$0.00
80355		0%	70	$0.00
A4649	Surgical supply; miscellaneous	0%	30	$0.00
80323		0%	14	$0.00
P9045	Infusion, albumin (human), 5%, 250 ml	0%	12	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	29	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	264	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	14	$0.00
80349		0%	15	$0.00
91305		0%	17	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	32	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWRIGHT, ALBERT (PRESIDENT/CEO)

Same official

Other billing entities under WRIGHT, ALBERT

Full network →

Provider	Location	Paid
West Virginia University Hospitals, INC.	Morgantown, WV	$15.42M
West Virginia University Hospitals, INC	Morgantown, WV	$3.03M
West Virginia University Hospitals, INC.	Uniontown, PA	$2.39M
West Virginia University Hospitals INC	Morgantown, WV	$426K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.